» Articles » PMID: 38488557

Association of DNA Methylation/demethylation with the Functional Outcome of Stroke in a Hyperinflammatory State

Overview
Date 2024 Mar 15
PMID 38488557
Authors
Affiliations
Soon will be listed here.
Abstract

JOURNAL/nrgr/04.03/01300535-202410000-00024/figure1/v/2024-02-06T055622Z/r/image-tiff Inflammation is closely related to stroke prognosis, and high inflammation status leads to poor functional outcome in stroke. DNA methylation is involved in the pathogenesis and prognosis of stroke. However, the effect of DNA methylation on stroke at high levels of inflammation is unclear. In this study, we constructed a hyperinflammatory cerebral ischemia mouse model and investigated the effect of hypomethylation and hypermethylation on the functional outcome. We constructed a mouse model of transient middle cerebral artery occlusion and treated the mice with lipopolysaccharide to induce a hyperinflammatory state. To investigate the effect of DNA methylation on stroke, we used small molecule inhibitors to restrain the function of key DNA methylation and demethylation enzymes. 2,3,5-Triphenyltetrazolium chloride staining, neurological function scores, neurobehavioral tests, enzyme-linked immunosorbent assay, quantitative reverse transcription PCR and western blot assay were used to evaluate the effects after stroke in mice. We assessed changes in the global methylation status by measuring DNA 5-mc and DNA 5-hmc levels in peripheral blood after the use of the inhibitor. In the group treated with the DNA methylation inhibitor, brain tissue 2,3,5-triphenyltetrazolium chloride staining showed an increase in infarct volume, which was accompanied by a decrease in neurological scores and worsening of neurobehavioral performance. The levels of inflammatory factors interleukin 6 and interleukin-1 beta in ischemic brain tissue and plasma were elevated, indicating increased inflammation. Related inflammatory pathway exploration showed significant overactivation of nuclear factor kappa B. These results suggested that inhibiting DNA methylation led to poor functional outcome in mice with high inflammation following stroke. Further, the effects were reversed by inhibition of DNA demethylation. Our findings suggest that DNA methylation regulates the inflammatory response in stroke and has an important role in the functional outcome of hyperinflammatory stroke.

Citing Articles

How epigenetics impacts stroke risk and outcomes through DNA methylation: A systematic review.

Gallego-Fabrega C, Cullell N, Fernandez-Cadenas I J Cereb Blood Flow Metab. 2025; :271678X251322032.

PMID: 40012472 PMC: 11866340. DOI: 10.1177/0271678X251322032.


ROS-regulated SUR1-TRPM4 drives persistent activation of NLRP3 inflammasome in microglia after whole-brain radiation.

Chang Y, He Y, Wang D, Zhang K, Zhang Y, Li Z Acta Neuropathol Commun. 2025; 13(1):16.

PMID: 39871308 PMC: 11771008. DOI: 10.1186/s40478-025-01932-1.


Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions.

He S, Zhou Z, Cheng M, Hao X, Chiang T, Wang Y MedComm (2020). 2025; 6(2):e70054.

PMID: 39822761 PMC: 11733107. DOI: 10.1002/mco2.70054.


Epigenetic regulation of the inflammatory response in stroke.

Liang J, Yang F, Li Z, Li Q Neural Regen Res. 2024; 20(11):3045-3062.

PMID: 39589183 PMC: 11881735. DOI: 10.4103/NRR.NRR-D-24-00672.


Neuroprotective potential for mitigating ischemia-reperfusion-induced damage.

Ye Z, Liu R, Wang H, Zuo A, Jin C, Wang N Neural Regen Res. 2024; 20(8):2199-2217.

PMID: 39104164 PMC: 11759025. DOI: 10.4103/NRR.NRR-D-23-01985.

References
1.
Liu S, Jin R, Xiao A, Zhong W, Li G . Inhibition of CD147 improves oligodendrogenesis and promotes white matter integrity and functional recovery in mice after ischemic stroke. Brain Behav Immun. 2019; 82:13-24. PMC: 6800638. DOI: 10.1016/j.bbi.2019.07.027. View

2.
Cui X, Chopp M, Zacharek A, Cui C, Yan T, Ning R . D-4F Decreases White Matter Damage After Stroke in Mice. Stroke. 2015; 47(1):214-20. PMC: 4702511. DOI: 10.1161/STROKEAHA.115.011046. View

3.
Nguyen J, Chauhan A . Bystanders or not? Microglia and lymphocytes in aging and stroke. Neural Regen Res. 2022; 18(7):1397-1403. PMC: 10075112. DOI: 10.4103/1673-5374.360345. View

4.
Anrather J, Iadecola C . Inflammation and Stroke: An Overview. Neurotherapeutics. 2016; 13(4):661-670. PMC: 5081118. DOI: 10.1007/s13311-016-0483-x. View

5.
Coveney S, Murphy S, Belton O, Cassidy T, Crowe M, Dolan E . Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic attack. Int J Stroke. 2021; 17(2):163-171. DOI: 10.1177/1747493021995595. View